Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignancies.
Rosenthal MA, Dennis D, Liebes L, Furmanski P, Caron D, Garrison L, Wiprovnick J, Peace D, Oratz R, Speyer J, Chachoua A.
Rosenthal MA, et al. Among authors: speyer j.
J Immunother. 1998 Sep;21(5):371-8. doi: 10.1097/00002371-199809000-00005.
J Immunother. 1998.
PMID: 9789199
Clinical Trial.